Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. - Test2 - elhamkhani - TriplyDB

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.

http://www.wikidata.org/entity/Q33508797

about

Haematological and biochemical reference values for healthy adults in the middle belt of Ghana Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.Community engagement in biomedical research in an African setting: the Kintampo Health Research Centre experience Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.Clustering of childhood mortality in the Kintampo Health and Demographic Surveillance System in Ghana.The RTS,S vaccine candidate for malaria.Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.Health providers' perceptions of clinical trials: lessons from Ghana, Kenya and Burkina Faso.Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial Adjuvants for Leishmania vaccines: from models to clinical application.Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.A pilot study to determine the normal haematological indices for young Malawian adults in Blantyre, Malawi.Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-naïve adults Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.From discovery to licensure, the Adjuvant System story.Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes.Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.Adjuvant system AS01: helping to overcome the challenges of modern vaccines.Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination.Le vaccin antipaludique RTS,S/AS01 chez les enfants âgés de 5 à 17 mois au moment de la première vaccination

P2860

Q28482726-1A142C0B-2793-4347-89A9-488A7C628454 Q28541281-3A26E025-3379-4D5C-A9EB-469CEBF2D78B Q28740701-7A70A4CD-7D7F-4047-967C-EA627F9147D9 Q30274995-3DBDD747-6FB7-4B77-9511-B998599EEB6E Q30352329-092158EC-E451-4A2A-9232-2728A3871FB3 Q33590277-1B855116-423C-42A1-97C7-A2CBC8AFA5A3 Q34043843-3A48C54B-EC69-44A8-8BD4-19609F20EA3F Q34122341-1EEBA436-DFCA-403D-9044-F21650E9AFD2 Q34186762-F2243FF5-35FD-4AEA-9B90-4A857E8F3D5A Q34193236-93CF0E7B-E865-4357-ABA0-C4FDC2641182 Q34487139-7B205672-FA5E-478E-91D0-CF4B06E4D77D Q34684347-2740EFFD-C498-4015-92CD-E1361CBB2DB4 Q35048336-EC566EDE-5EC8-428C-9617-C087E5DBCEFA Q35560610-39F945D0-6D05-465A-BA99-D16F7675BC70 Q35867612-41E1D907-463F-4110-9BAC-ED766BA51512 Q35925829-D960AA01-B355-4A55-BA29-46B15B81D7CE Q36021357-FB99CE4E-D747-4A14-AAC5-9D0C7731D587 Q36176551-C4B5C161-566A-4E36-BA4A-7CEDDC73B33A Q36362230-0C855972-75DF-4EB6-8D73-5756CDBFDA11 Q36397770-EFE65AC2-1A95-467D-9EAF-0FA3F1AA5CD7 Q36568190-7001C475-ADBB-4D9F-9323-9831022DBAF9 Q36851744-917E7A39-43B0-46CD-BFE8-3FC740894418 Q36978351-855986E0-0832-442C-B8E3-1F41732CCDB5 Q37336064-FCFA1FEF-1407-462C-879E-D08C65CDB3A8 Q37619140-CAB734F5-5368-458C-9388-AE00BCF78253 Q37641676-373BEADB-0CAD-46FF-96FD-A7E81A83AFCC Q37867102-B03899CE-1A00-428D-A900-CBE89B0009A6 Q38599514-E47FBFA3-79F8-40BD-8BDB-C88C28317EA9 Q42051427-A0DCA418-C094-4CAC-BC8E-21B950EC848E Q42126049-CB3F0954-CBFD-4558-88CD-69AE5F253A10 Q47977891-06F7F45A-707B-49F2-95BE-76A8E3615D3D Q58131059-179C5C2D-A1F8-4E7A-9C3A-4B0A3AA5A7D8

P2860

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.

http://www.wikidata.org/entity/Q33508797

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Randomized controlled trial of ...... chedules in Ghanaian children.

@ast

Randomized controlled trial of ...... chedules in Ghanaian children.

@en

type

label

Randomized controlled trial of ...... chedules in Ghanaian children.

@ast

Randomized controlled trial of ...... chedules in Ghanaian children.

@en

prefLabel

Randomized controlled trial of ...... chedules in Ghanaian children.

@ast

Randomized controlled trial of ...... chedules in Ghanaian children.

@en

P1433

Q33508797-F57AD6BB-36DD-41E2-AB6D-C0BE5829E168

P1476

Q33508797-45E04F47-4562-4972-85A4-F530BC9228CF

P2093

Q33508797-0FD3A1A5-ECA2-4CEC-AEA3-6FDB24582812

Q33508797-112CB2EE-A28E-44A7-8344-1FFA7DB8BC36

Q33508797-14C24B1B-5611-4CF7-BD56-7D16E43F067C

Q33508797-2550AA60-621F-4988-839F-C2DF132C59BB

Q33508797-2E67CF8E-9F93-4398-8968-7D57DB1D5AB9

Q33508797-551A9E2C-9C37-4A76-859D-9B8D7BA74F54

Q33508797-5583BD76-4DEC-49E7-8B8E-DA4221F66171

Q33508797-5C6C37CF-2E68-4A45-90F8-CCCEF1150691

Q33508797-5E9BAD6F-8442-488E-871D-7E5207591EFC

Q33508797-753D2083-7278-4960-9808-B7BE3E1060B2

P2860

Q33508797-205BCAB4-0113-4815-9A76-B16E56A154D1

Q33508797-2D09B88D-1929-48BA-8710-205BC69E7B2A

Q33508797-2F285FFA-2A2B-4444-85FD-28E4C76E3541

Q33508797-3C9F7FEE-34FF-457D-833A-9B68F9C431B8

Q33508797-731CB920-2E22-47A1-BDB1-E9C55B855A3A

Q33508797-7D2C5270-23B7-4C22-84D9-D75E57B1360C

Q33508797-8F574BE9-014A-43AF-890A-9BCBB4938F3C

Q33508797-94A9646E-E82C-42F6-B77A-D889EEFDEFF5

Q33508797-A541EA8F-B92A-47E3-9F75-6743525EF140

Q33508797-B00BFF62-06C1-46FD-803E-84CCB7516F1E

P304

Q33508797-F88895AC-7232-49D5-9409-392A1038F0BE

P31

Q33508797-6CFED310-37C5-4651-8C04-2A76F1FFCE5B

P356

Q33508797-5A60780F-8915-4314-A81A-641FAB603630

P407

Q33508797-F43B482F-2032-4C58-BB99-E8042EC4B2C4

P433

Q33508797-006446FF-CB67-417F-B9B9-967273091060

P478

Q33508797-11915393-959C-49E7-A1DD-1AE31C2C16E8

P50

Q33508797-1CD5C04B-5791-4D72-A00D-098A2E0BE039

Q33508797-5AAD12E9-37DF-4C46-9DD5-EA8BEF0BD3DF

Q33508797-7C1F5CD3-EC3B-4469-892F-445CCAB74C20

Q33508797-80E85C73-72CB-43E9-99C4-BECD2EA335BE

Q33508797-8701440D-550C-4BBD-90FB-483D8EFE05FF

Q33508797-9BB9DF81-401F-4E2B-817B-BF9195392648

Q33508797-B5551886-C12C-4796-A96C-431E06994057

Q33508797-B716BAE6-7564-4421-8B46-235056065509

Q33508797-C48AE31A-482F-4656-BC10-8F376D3291AB

Q33508797-E52ADD69-B077-49A9-A56F-CB129E11755C

P577

Q33508797-F892EEC1-4AF5-4040-817E-8EBFFE827D24

P5875

Q33508797-B045B23B-EFD6-433E-9912-6E21EDF975C8

P698

Q33508797-BFC8953E-EE14-4155-AC32-5D0EE507DFB2

P921

Q33508797-D84561A3-E765-47D2-80FD-60A45B368DAF

P932

Q33508797-7AB190A2-32F5-428C-97ED-6881CA4DD460

P356

JOURNAL.PONE.0007302

P1433

P1476

Randomized controlled trial of ...... chedules in Ghanaian children.

@en

P2093

Alex Osei Akoto

http://www.w3.org/2001/XMLSchema#string

Amanda Leach

http://www.w3.org/2001/XMLSchema#string

Barbara Savarese

http://www.w3.org/2001/XMLSchema#string

David Dosoo

http://www.w3.org/2001/XMLSchema#string

David Sambian

http://www.w3.org/2001/XMLSchema#string

Emmanuel Asafo Adjei

http://www.w3.org/2001/XMLSchema#string

George Adjei

http://www.w3.org/2001/XMLSchema#string

Jennifer Evans

http://www.w3.org/2001/XMLSchema#string

Joe Cohen

http://www.w3.org/2001/XMLSchema#string

Johan Vekemans

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.

Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.

A new global effort to control malaria.

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique.

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

P304

e7302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007302

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Seth Owusu-Agyei

Kingsley Osei-Kwakye

Brian Greenwood

Paul J. Milligan

Daniel Chandramohan

Justice Sylverken

Tsiri Agbenyega

W Ripley Ballou

P577

2009-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26873285

http://www.w3.org/2001/XMLSchema#string

P698

19806184

http://www.w3.org/2001/XMLSchema#string

P921

P932

2750750

http://www.w3.org/2001/XMLSchema#string